Stay updated on FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Sign up to get notified when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.

Latest updates to the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check21 days agoChange DetectedAn NIH-wide banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference0.7%

- Check28 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check35 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry labeled v3.7.0 was added to the study record history, updating the version history; the previous revision v3.6.6 appears to be removed from the list.SummaryDifference0.1%

- Check77 days agoChange DetectedThe FRIDA study (NCT05546580) updated its recruitment status from Recruiting to Active, not recruiting, with a new note that no participants are being sought. The record also adds/updates the Contacts/Locations and Study Status sections and shows a new revision (v3.6.6).SummaryDifference1%

Stay in the know with updates to FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML
Enter your email address, and we'll notify you when there's something new on the FRIDA Clinical Trial: Iadademstat & Gilteritinib in FLT3 Mut+ AML page.